Overview

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

Status:
Unknown status

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

Summary

This adaptive seamless Phase II/III trial is to compare the efficacy and safety of adjuvant systemic chemotherapy (SCT) with or without hepatic arterial infusion (HAI) after complete hepatic resection for Chinese patients with metastatic colorectal cancer.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Ye Xu

Treatments:

Capecitabine
Dexamethasone
Floxuridine
Fluorouracil
Heparin
Leucovorin
Levoleucovorin
Oxaliplatin